CEL, CPA1, and CPB1 code for carboxyl ester lipase, carboxypeptidase A1, and carboxypeptidase B1, respectively, and their downregulation is again indicative of pancreatic exocrine insufficiency associated with onset of malignancy in benign IPMNs. Here, CPB1 is linked to exocrine pancreatic insufficiency.